ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (01541)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Zhang Wei | 29-Jul-24 | Sup | |||
| Guan Mei | 28-May-24 | ED | |||
| Li Kin Wai | 14-Jun-22 | CoSec | |||
| Guan Mei | 14-Jun-22 | CoSec | |||
| Yeung Rex Chi Tat | 14-Jun-22 | INED | |||
| Smith Kendall Arthur | 14-Jun-22 | INED | |||
| Zhao Zimeng | 17-Jan-22 | Sup | |||
| Xu Cong | 14-Oct-20 | NED | |||
| Tian Miao | 24-Jul-17 | Sup | |||
| Zhu Zhenping | 03-Aug-16 | INED | |||
| Li Song | 17-Dec-15 | ED | |||
| Tian Wenzhi | 18-Jun-15 | CEO, Ch, Fdr | |||
| Yu Zhihua | 30-Mar-18 | 14-Oct-24 | NED | In order to devote more time to his other business commitments. | |
| Yu Xiaoyong | 15-Dec-15 | 30-Sep-24 | NED | In order to devote more time to his other business commitments. | |
| Gu Jiefeng | 01-Mar-16 | 29-Jul-24 | Sup Ch | In order to devote more time to his other business commitments | |
| Gu Jiefeng | 29-Jul-24 | Member of the Supervisory Committee | In order to devote more time to his other business commitments | ||
| Song Ziyi | 17-Jan-22 | 02-Mar-24 | FD | In order to devote more time to her other business commitments | |
| Song Ziyi | 02-Mar-24 | ED | In order to devote more time to her other business commitments |